Development of a human cellular TBK1 model for drug discovery in ALS

Ended Project Grant Awarded Last action

Award ID
R43NS110339
Recipient
Awarding agency
Obligated
$224,119

Award facts

Assistance listing
93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders
Completion date
Place of performance
Cambridge, MA 02139, USA

Award details come from USAspending.gov.

Transactions

Action Obligated Date
Amendment $0
Amendment Development of a human cellular TBK1 model for drug discovery in ALS - program summary. Amyotrophic lateral sclerosis (ALS) affects an estimated 30,000… $0
Original award $224,119

Quick answers

Who received award R43NS110339?

R43NS110339 was awarded to Quralis Corporation by National Institute of Neurological Disorders and Stroke (National Institutes of Health) on September 30, 2019.

How much is award R43NS110339 worth?

$224,119 has been obligated on R43NS110339.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award